Clinical Trials in Boston

Showing 2541-2560 of 15,299 trials

A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC

NCT04175041

To determine the cognitive and neurophysiological dose-response relationships of anodal tDCS to the left DLPFC as a function of absolute current intensity, individualized E-field intensity, and stimulation duration.

Attention Deficit Hyperactivity Disorder

Massachusetts General Hospital104 participantsStarted Jul 2019

Boston, Massachusetts, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

NCT06153693

This is a Phase 3 trial to evaluate the BP-lowering effect of lorundrostat (an aldosterone synthase inhibitor) in subjects with uncontrolled and resistant hypertension taking between 2 and 5 anti-hypertensive (AHT) medications.

Hypertension

Mineralys Therapeutics Inc.1,083 participantsStarted Nov 2023

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +181 more locations

A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC

Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

Find Trials by Condition in Boston

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

Cognitive Control to Boost Physical Activity Adherence

A Study of HBS-201 (Pitolisant Delayed-release)

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

A Study of Zigakibart in Adults With IgA Nephropathy

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant